VMS Rehab Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRSYF research report →
About the company
VMS Rehab Systems, Inc. maintains operations across two distinct fields: generic pharmaceuticals and home healthcare. A significant part of its pharmaceutical efforts involves the creation and rigorous evaluation of generic versions of tadalafil.
- CEO
- Michael S. Wexler
- IPO
- 2015
- Employees
- 5
- HQ
- Ottawa, ON, CA
Price Chart
- Market Cap
- $156.17K
- P/E
- 0.00
- P/S
- 2178.02
- P/B
- -0.00
- EV/EBITDA
- -2280.07
- Div Yield
- 0.00%
- Gross Margin
- -14.56%
- Op Margin
- -95.76%
- Net Margin
- 64.78%
- ROE
- -20.14%
- ROIC
- 108.33%
- Revenue
- $71.701 · 19.67%
- Net Income
- $46.445 · 639.87%
- EPS
- $0.17 · 0.00%
- Op Income
- $-68.661
- FCF YoY
- -21.19%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.21
- Avg Volume
- 8.32K
Get TickerSpark's AI analysis on VRSYF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VRSYF coverage
Recent articles, reports, and earnings notes.
No research on VRSYF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRSYF report →Similar companies
Peers in the same neighborhood.